References
- Abe T, Morgan DA, Gutterman DD (1997): Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 85: 213–220.
- Aloe L, Micera A (1999): Nerve growth factor: basic findings and clinical trials. Biomed Rev 10: 3–14.
- Anada P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV (1996): The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2: 703–707.
- Apfel SC (1999): Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med 107(2B): 34S–42S.
- Bu G, Sun Y, Schwartz AL, Holtzman DM (1998): Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. J Biol Chem 273: 13359–13365.
- Chaldakov GN, Fiore M, Stankulov IS, Triaca V, Ghenev PI, Aloe L (1999): Neuroimmune hypothesis of atherosclero-sis. Biomed Rev 10: 37–44.
- Chaldakov GN, Fiore M, Ghenev PI, Stankulov IS, Aloe L (2000a): Atherosclerotic lesions: possible interactive involvement of intima, adventitia and associated adipose tissue. Int Med J 7: 43–49.
- Chaldakov GN, Fiore M, Hristova M, Aloe L (2000b): Cell biology and pharmacology of adipose tissue secretion. FABAD J Pharm Sci 25: 181–191.
- Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tes-sarollo L, Mahadeo D, Sharif S, Kaplan DR, Tsoulfas P, Parada L, Hempstead BL (1995): Neurotrophin and neu-rotrophin receptors in vascular smooth muscle cells. Regu-lation in response to injury. Am J Pathol 147: 309–324.
- Groop L (2000): Genetics of the metabolic syndrome. Br J Nutr 83 (Suppl 1): S39–S48.
- Kaye DM, Vaddadi G, Gruski SL, Du X-J, Esler MD (2000): Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 86: e80–e84.
- Nagtegaal ID, Lakke EAJF, Marani E (1998): Trophic and tropic factors in the development of the central nervous system. Arch Physiol Biochem 106: 161–202.
- Ono M, Itakura Y, Nonomura T, Nakagawa T, Nakayama C, Taiji M (2000): Intermittent administration of brain-derived neu-rotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 49: 129–133.
- Ross R (1999): Mechanisms of disease: atherosclerosis — an inflammatory disease. N Engl J Med 340: 115–126.
- Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull JrW, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995): A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Com-mittee on Vascular Lesions of the Council on Arterioscle-rosis, American Heart Association. Circulation 92: 1355–1374.
- Wang S, Bray P, McCaffrey T, March K, Hempstead BL, Kraemer R (2000): p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. Am J Pathol 157: 1247–1258.
- Yokata T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Termer AJ, Tomiyama Y, Matsuzawa Y (2000): Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages. Blood 96: 1723–1732.
- Zimmer P, Boyko EJ, Collier GR, de Courten M (1999): Etiol-ogy of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann NY Acad Sci 892: 25–44.